Fig 1 - by Fatemeh Mohammadkhani (15927311)

Subjects:

Importance of facilitating dispersal for mammals with 4.5°C warming. by Rhosanna L. M. Jenkins (11167230)

Importance of facilitating dispersal for birds with 4.5°C warming. by Rhosanna L. M. Jenkins (11167230)

Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…The original traces were taken at the time points indicated by the numbers 1–3. (<b>C</b>) The inhibitory effect of DHPG on GlyR-IPSCs was blocked by MPEP (92.4 ± 4.4% of baseline at 15–20 min post-DHPG, <i>t</i>[5] = 1.573, <i>p</i> = 0.177) but not by CPCCOEt (53.5 ± 3.7% of baseline at 15–20 min post-DHPG, <i>t</i>[5] = 14.343, <i>p</i> < 0.001). …”

cGAS inhibition decreases ISG RNA in H358 cells. by Lorellin A. Durnell-Bettis (22656332)

ENaC activity is decreased in oocytes expressing wild type S protein. by Germán Ricardo Magaña-Ávila (18446799)

Increased sensitivity to amphetamine and decreased sensitivity diazepam cKO mice. by Robert Fredriksson (27811)

Modifying pregnenolone to decrease its lipophilicity results in decreased cellular uptake. by Jeffrey M. McManus (7512926)

Design, Synthesis, and Biological Evaluation of [1,2,5]Oxadiazolo[3,4‑<i>b</i>]pyridin-7-ol as Mitochondrial Uncouplers for the Treatment of Obesity and Metabolic Dysfunction-Assoc... by Mary A. Foutz (20361830)

“…Mitochondrial uncouplers such as BAM15 increase respiration and energy expenditure and have potential in treating a variety of metabolic diseases. In this study, we disclose the structure–activity relationship profile of 6-substituted [1,2,5]oxadiazolo[3,4-<i>b</i>]pyridin-7-ol derivatives of BAM15. …”

HealthRise patient shifts in disease severity categories between baseline and endline based on biometric readings for hypertension (A) and diabetes (B). by Nancy Fullman (243628)

Contains underlying data for Figs 1A, 1F, 1G, 1I, 1J, 2D, 2E, 2G, 2H, 2J, 2K, 2M, 2N, 3A, 3B, 3C, 3D, 3F, 4A, 4B, 4C, 4D, 4E, 5I, 6A, 6B, 6D, 6F, 7B, 7D, and 7F and S1A, S1B, S3A,... by Xiao Chen Shi (8611887)

Detailed test procedure for sample 5. by Yanbo Cao (8816477)

In the first 15 days of pod fill high temperature over 30∘C decreased marketable yield for both seasons. by Miranda Y. Mortlock (20855564)

Cardiac-specific p38γ/δ^act overexpression decreases cardiac glycogen storage and lipid accumulation. by Ayelén M. Santamans (5487941)

Supplementary Data Table 4 from Physical Activity Decreases Inflammation and Delays the Development of Obesity-Associated Pancreatic Ductal Adenocarcinoma by Valentina Pita-Grisanti (19677089)

Decreased echinocandin susceptibility in <i>Candida parapsilosis</i> causing candidemia and emergence of a pan-echinocandin resistant case in China by Yating Ning (11264310)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”